Olympus (TYO:7733) said yesterday it launched the Endoeye Flex 3D and FlexDex needle driver laparoscopic surgical tools in the U.S. The company said that it is the exclusive distributor for DexFlex in the US, and is combining the Endoeye Flex 3D tech with FlexDex’s wristed needle-driver to improve minimal access surgery procedures. The device can be used […]
Report: Abbott CEO White selects possible successor
Abbott (NYSE:ABT) CEO Miles White may have chosen an eventual successor to take over the corner office, according to a new Forbes report. White, who has been at the head of Abbott for 20 years, named long-time exec Robert Ford as the company’s president and COO, according to the report.The appointment marks the first time an […]
PolarityTE responds to short-seller report
PolarityTE yesterday responded to a scathing report from Citron Research which accused the company of fraud, saying that the report was used by short sellers to drop the company’s share value. The Salt Lake City, Utah.-based company said that the publication is “well-known to be used as a tool by notorious short sellers” and that […]
Report: IBM Watson Health head DiSanzo steps down
International Business Machine‘s (NYSE:IBM) Watson Health GM Deborah DiSanzo is stepping away from her position heading the division to join the strategy team for IBM Cognitive Solutions, according to a STAT News report. Cognitive Solutions and IBM Research senior VP John Kelly will step in to take the reins of the healthcare-focused division, according to […]
FDA approves Abbott’s HeartMate 3 as a destination therapy
Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure. With the approval, the Chicago-based company said that the device can now be used in patients not eligible for a transplant as a life-long implant. “We partner with […]
NuVasive taps Medtronic surgical innovation prez Barry as new CEO | Personnel Moves – October 19, 2018
NuVasive (NSDQ:NUVA) said today it named Medtronic (NYSE:MDT) surgical innovations prez J. Barry as its new CEO, replacing Gregory Lucier, effective November 5. Barry will also join the company’s board of directors, where Lucier will continue to serve as board chair and aid in transition efforts, the San Diego-based company said. NuVasive also said that it promoted current strategy, […]
NxStage touts home hemodialysis study data
NxStage Medical (NSDQ:NXTM) today released data from a study comparing home hemodialysis to traditional treatment in a skilled nursing facility, touting a lower risk of death and cardiovascular hospitalization for those treated more often with home hemodialysis. Full results from the trial are slated to be presented at the American Society of Nephrology Kidney Week 2018 […]
Synoste raises $6m for skeletal deformation tech
Medtech firm Synoste has raised $5.8 million (EU €5.1 million) to support its patented skeletal deformation correction tech. Funding came from Lifeline Ventures and AO Invest, the Finnish company said, and raises the total the company has raised to approximately $11.5 million (EU €10 million) so far. “Synoste is exactly the type of company that […]
FDA clears Viseon’s Voyant MIS spinal surgery tech
Early stage, spinal-focused medical device maker Viseon said today it won FDA 510(k) clearance for its minimally-invasive Voyant system intended for accessing, visualizing and illuminating spinal procedures. The Voyant system is composed of a sterile single-use, disposable retractor device featuring integrated visualization technology and a reusable controller for manipulation of the surgical site image. The […]
U Penn trial regrows dental pulp from baby tooth stem cells
Data from recent clinical trial out of the University of Pennsylvania suggest that the use of stem cells from a patient’s baby teeth could be used to help regrow dental pulp tissue. Results from the trial, which was conducted in China, were published in the journal Science Translational Medicine. In the trial, 40 children were […]
TransEnterix CEO Pope makes Time’s 50 Most Influential People in Healthcare
TransEnterix (NYSE:TRXC) said today that its president and CEO Todd Pope has been named to Time Magazine’s Most Influential People in Health Care for 2018, highlighted for their work bringing the Senhance robotic surgical platform to the market. Pope was an inaugural selection for the list, which Time Magazine said it assembled to highlight “physicians, scientists, and […]
- 1
- 2
- 3
- …
- 510
- Next Page »
MassDevice Network
@MassDevice
LinkedIn